Zhitong Financial APP learned that Zhitong Financial APP learned that according to the IPO documents disclosed by the Hong Kong Stock Exchange on July 9, Yida Health Healthcare Technology Holdings Co., Ltd., the pioneer of intelligent precision surgical solutions, submitted an application for listing on the main board, with Morgan Stanley and China International Capital Corporation as its co-sponsors.

In the solution of precision surgery, surgical robot and accurate surgical planning solution are two major areas, including surgical robot and precision surgical planning solution. With more than 15 years of focus on precision surgery solutions, Yinda Health has gradually established a comprehensive and complete product line of precision surgery solutions, including its main assets and core products-IQQA-Guide series of surgical robots and a rich line of precision surgery planning software, including IQQA-3D. The company has established a 3D precision surgery digital solution cloud platform ("IQQA cloud platform") in China, which integrates the core functions of IQQA-3D and enables doctors to collaborate on intelligent surgery planning remotely in real time.

Through IQQA-3D and IQQA cloud platforms, the company has assisted more than 70000 precision operations in China, covering more than 60 of the top 100 hospitals published by the Institute of Medical Management of Fudan University. Its precision surgery planning software is also registered in the United States, where it won the 2011 North American Frost Sullivan Technical Innovation Award and the 2016 North American Frost Sullivan Product leadership Award, and successfully infiltrated a number of world-renowned hospitals, such as Miaoyou Medical International.

According to the prospectus, the company is led by a world-class scientific management team. Its founder, Dr. QianJianzhong, is a world-renowned scientist who holds more than 200 patents and is a fellow member of the American Society of Medicine and Bioengineering.

The company's products include percutaneous surgery robots (IQQA-Guide series), precision surgery solutions, consumables products.

All of Yida Health's products and candidate products are developed by its internal R & D team, which consists of more than 50 employees as of the last practical date. All of its products are manufactured by an in-house manufacturing team, and medical device software ("SaMD") products are manufactured and installed on computers based on the target market at a base in New Jersey or Shanghai.